Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning

The level of Epstein-Barr virus DNA in blood has proven to be a biomarker with some predictive value in allogeneic hematopoietic stem cell transplantation patients (HSCT). We evaluated the impact of EBV load on survival of 51 patients (32M/19F, median age: 32 years, from < 1 to 68 years old), who...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qin, Rane, Lalit, Poiret, Thomas, Zou, Jiezhi, Magalhaes, Isabelle, Ahmed, Raija, Du, Ziming, Vudattu, Nalini, Meng, Qingda, Gustafsson-Jernberg, Åsa, Winiarski, Jacek, Ringdén, Olle, Maeurer, Markus, Remberger, Mats, Ernberg, Ingemar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058676/
https://www.ncbi.nlm.nih.gov/pubmed/27102298
http://dx.doi.org/10.18632/oncotarget.8803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058676/
https://www.ncbi.nlm.nih.gov/pubmed/27102298
http://dx.doi.org/10.18632/oncotarget.8803

Ejemplares similares